All Stories

  1. Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: Long-term outcomes of a prospective randomized trial

    Article • Cancer, March 2017, Wiley

    Dr Ying-Jun Chang

  2. Regulatory B cells promote graft-versus-host disease prevention and maintain graft-versus-leukemia activity following allogeneic bone marrow transplantation

    Article • OncoImmunology, February 2017, Taylor & Francis

    Dr Ying-Jun Chang

  3. Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation

    Article • Journal of Immunology Research, January 2017, Hindawi Publishing Corporation

    Dr Ying-Jun Chang

  4. Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized study

    Article • OncoImmunology, October 2016, Taylor & Francis

    Dr Ying-Jun Chang

  5. The impact of minimal residual disease prior to unmanipulated haploidentical hematopoietic stem cell transplantation in patients with acute myeloid leukemia in complete remission

    Article • Leukemia & Lymphoma, October 2016, Taylor & Francis

    Dr Ying-Jun Chang

  6. Increased Type 1 Immune Response in the Bone Marrow Immune Microenvironment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, August 2016, Elsevier

    Dr Ying-Jun Chang

  7. Impact of pre-transplant pulmonary infection developed in horizontal laminar flow unit on the outcome of subsequent allogeneic hematopoietic stem cell transplantation

    Article • Journal of Thoracic Disease, August 2016, AME Publishing Company

    Dr Ying-Jun Chang

  8. Early lymphocyte recovery predicts superior outcomes after unmanipulated haploidentical blood and marrow transplant for acute myeloid leukemia

    Article • Clinical Transplantation, June 2016, Wiley

    Dr Ying-Jun Chang

  9. Rapid Recovery of CD3+CD8+ T Cells on Day 90 Predicts Superior Survival after Unmanipulated Haploidentical Blood and Marrow Transplantation

    Article • PLoS ONE, June 2016, PLOS

    Dr Ying-Jun Chang

  10. Controlled, Randomized, Open-Label Trial of Risk-Stratified Corticosteroid Prevention of Acute Graft-Versus-Host Disease After Haploidentical Transplantation

    Article • Journal of Clinical Oncology, June 2016, American Society of Clinical Oncology (ASCO)

    Dr Ying-Jun Chang

  11. How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?

    Article • Journal of Hematology & Oncology, April 2016, Springer Science + Business Media

    Dr Ying-Jun Chang

  12. Haploidentical stem cell transplantation: anti-thymocyte globulin-based experience

    Article • Seminars in Hematology, April 2016, Elsevier

    Dr Ying-Jun Chang

  13. Combined model of the EBMT score modified model and the HCT-CI improves the stratification of high-risk patients undergoing unmanipulated haploidentical blood and marrow transplantation

    Article • Leukemia & Lymphoma, February 2016, Informa Healthcare

    Dr Ying-Jun Chang

  14. Differential impact of two doses of antithymocyte globulin conditioning on lymphocyte recovery upon haploidentical hematopoietic stem cell transplantation

    Article • Journal of Translational Medicine, December 2015, Springer Science + Business Media

    Dr Ying-Jun Chang

  15. The impact of donor characteristics on the immune cell composition of mixture allografts of granulocyte-colony-stimulating factor-mobilized marrow harvests and peripheral blood harvests

    Article • Transfusion, August 2015, Wiley

    Dr Ying-Jun Chang

  16. The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantation

    Article • Annals of Hematology, July 2015, Springer Science + Business Media

    Dr Ying-Jun Chang

  17. Recipient expression of ligands for donor inhibitory KIRs enhances NK-cell function to control leukemic relapse after haploidentical transplantation

    Article • European Journal of Immunology, May 2015, Wiley

    Xiao-Jun Huang, Dr Ying-Jun Chang

  18. Haploidentical stem cell transplantation for the treatment of leukemia: current status

    Article • Expert Review of Hematology, September 2014, Informa Healthcare

    Dr Ying-Jun Chang

  19. Immune Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, April 2014, Elsevier

    Dr Ying-Jun Chang

  20. Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation

    Article • Journal of Translational Medicine, January 2014, Springer Science + Business Media

    Dr Ying-Jun Chang

  21. Improving Cytomegalovirus-Specific T Cell Reconstitution after Haploidentical Stem Cell Transplantation

    Article • Journal of Immunology Research, January 2014, Hindawi Publishing Corporation

    Dr Ying-Jun Chang

  22. Association of an Impaired Bone Marrow Microenvironment with Secondary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, October 2013, Elsevier

    Dr Ying-Jun Chang

  23. Early lymphocyte recovery predicts superior overall survival after unmanipulated haploidentical blood and marrow transplant for myelodysplastic syndrome and acute myeloid leukemia evolving from myelodysplastic syndrome

    Article • Leukemia & Lymphoma, May 2013, Taylor & Francis

    Dr Ying-Jun Chang

  24. Ceruloplasmin Is a Potential Biomarker for aGvHD following Allogeneic Hematopoietic Stem Cell Transplantation

    Article • PLoS ONE, March 2013, PLOS

    Dr Ying-Jun Chang

  25. Early Lymphocyte Recovery Predicts Superior Overall Survival After Unmanipulated Haploidentical Blood and Marrow Transplantation for MDS and Acute Myeloid Leukemia Evolving From MDS

    Article • Biology of Blood and Marrow Transplantation, February 2013, Elsevier

    Dr Ying-Jun Chang

  26. Donor lymphocyte infusions for relapse after allogeneic transplantation. When, if and for whom?

    Article • Blood Reviews, January 2013, Elsevier

    Dr Ying-Jun Chang

  27. Haploidentical Bone Marrow Transplantation Without T-Cell Depletion

    Article • Seminars in Oncology, December 2012, Elsevier

    Dr Ying-Jun Chang

  28. Haploidentical hematopoietic stem cell transplantation with unmanipulated granulocyte colony stimulating factor mobilized marrow and blood grafts

    Article • Current Opinion in Hematology, November 2012, Wolters Kluwer Health

    Dr Ying-Jun Chang

  29. Characteristics and influencing factors of CD19+ B cell reconstitution in patients following haploidentical/mismatched hematopoietic stem cell transplantation

    Article • International Journal of Hematology, June 2012, Springer Science + Business Media

    Dr Ying-Jun Chang

  30. Peripheral blood stem cell transplantation or bone marrow transplant in allogeneic settings: Which should be chosen?

    Article • Leukemia Research, May 2012, Elsevier

    Dr Ying-Jun Chang

  31. Immune Reconstitution Following Unmanipulated HLA-Mismatched/Haploidentical Transplantation Compared with HLA-Identical Sibling Transplantation

    Article • Journal of Clinical Immunology, December 2011, Springer Science + Business Media

    Dr Ying-Jun Chang

  32. Conflicting Impact of Alloreactive NK Cells on Transplantation Outcomes after Haploidentical Transplantation: Do the Reconstitution Kinetics of Natural Killer Cells Create These Differences?

    Article • Biology of Blood and Marrow Transplantation, October 2011, Elsevier

    Dr Ying-Jun Chang

  33. Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials

    Article • Annals of Hematology, July 2011, Springer Science + Business Media

    Dr Ying-Jun Chang

  34. The impact of graft composition on clinical outcomes in pediatric patients undergoing unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation

    Article • Pediatric Blood & Cancer, March 2011, Wiley

    Dr Ying-Jun Chang

  35. Unmanipulated HLA-Mismatched/Haploidentical Blood and Marrow Hematopoietic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, February 2011, Elsevier

    Dr Ying-Jun Chang

  36. Clinical impact of absolute lymphocyte count on day 30 after unmanipulated haploidentical blood and marrow transplantation for pediatric patients with hematological malignancies

    Article • American Journal of Hematology, January 2011, Wiley

    Dr Ying-Jun Chang

  37. Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review

    Article • Clinical Transplantation, January 2011, Wiley

    Dr Ying-Jun Chang

  38. The impact of CD34+cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation

    Article • Pediatric Blood & Cancer, December 2009, Wiley

    Dr Ying-Jun Chang

  39. Influence of Lymphocyte Recovery on Outcome of Haploidentical Transplantation for Hematologic Malignancies

    Article • Medicine, November 2009, Wolters Kluwer Health

    Dr Ying-Jun Chang

  40. Expression of CD62L on Donor CD4+ T Cells in Allografts: Correlation with Graft-Versus-Host Disease after Unmanipulated Allogeneic Blood and Marrow Transplantation

    Article • Journal of Clinical Immunology, May 2009, Springer Science + Business Media

    Dr Ying-Jun Chang

  41. Platelet Engraftment in Patients with Hematologic Malignancies following Unmanipulated Haploidentical Blood and Marrow Transplantation: Effects of CD34+ Cell Dose and Disease Status

    Article • Biology of Blood and Marrow Transplantation, May 2009, Elsevier

    Dr Ying-Jun Chang

  42. High CD4/CD8 ratio in allografts predicts adverse outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation for chronic myeloid leukemia

    Article • Annals of Hematology, March 2009, Springer Science + Business Media

    Dr Ying-Jun Chang

  43. Treating donor mice with rhIL-11 and rhG-CSF promotes transplant-tolerance and preserves the effects of GVL after allogeneic bone marrow transplantation

    Article • Leukemia Research, January 2009, Elsevier

    Dr Ying-Jun Chang

  44. Effects of the NK Cell Recovery on Outcomes of Unmanipulated Haploidentical Blood and Marrow Transplantation for Patients with Hematologic Malignancies

    Article • Biology of Blood and Marrow Transplantation, March 2008, Elsevier

    Dr Ying-Jun Chang